ID   UFO_HUMAN               Reviewed;         894 AA.
AC   P30530; Q8N5L2; Q9UD27;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-JUN-2009, sequence version 3.
DT   02-NOV-2010, entry version 120.
DE   RecName: Full=Tyrosine-protein kinase receptor UFO;
DE            EC=2.7.10.1;
DE   AltName: Full=AXL oncogene;
DE   Flags: Precursor;
GN   Name=AXL; Synonyms=UFO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-266.
RX   MEDLINE=91062389; PubMed=2247464; DOI=10.1073/pnas.87.22.8913;
RA   Partanen J., Maekelae T.P., Alitalo R., Lehvaeslaiho H., Alitalo K.;
RT   "Putative tyrosine kinases expressed in K-562 human leukemia cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8913-8917(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND VARIANT ASP-266.
RC   TISSUE=Fibroblast;
RX   MEDLINE=92017777; PubMed=1656220;
RA   O'Bryan J.P., Frye R.A., Cogswell P.C., Neubauer A., Kitch B.,
RA   Prokop C., Espinosa R., le Beau M.M., Earp H., Liu E.T.;
RT   "AXL, a transforming gene isolated from primary human myeloid leukemia
RT   cells, encodes a novel receptor tyrosine kinase.";
RL   Mol. Cell. Biol. 11:5016-5031(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), AND VARIANT ASP-266.
RX   MEDLINE=92050809; PubMed=1834974;
RA   Janssen J.W.G., Schulz A.S., Steenvoorden A.C.M., Schmidberger M.,
RA   Strehl S., Ambros P., Bartram C.R.;
RT   "A novel putative tyrosine kinase receptor with oncogenic potential.";
RL   Oncogene 6:2113-2120(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG), AND VARIANT
RP   ASP-266.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 674-730.
RX   MEDLINE=94067791; PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 677-730, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Colon tumor;
RX   MEDLINE=95204052; PubMed=7896447; DOI=10.1002/ijc.2910600611;
RA   Craven R.J., Xu L.H., Weiner T.M., Fridell Y.-W., Dent G.A.,
RA   Srivastava S., Varnum B., Liu E.T., Cance W.G.;
RT   "Receptor tyrosine kinases expressed in metastatic colon cancer.";
RL   Int. J. Cancer 60:791-797(1995).
RN   [8]
RP   FUNCTION AS CELL ENTRY FACTOR IN FILOVIRUS INFECTION.
RX   PubMed=17005688; DOI=10.1128/JVI.01157-06;
RA   Shimojima M., Takada A., Ebihara H., Neumann G., Fujioka K.,
RA   Irimura T., Jones S., Feldmann H., Kawaoka Y.;
RT   "Tyro3 family-mediated cell entry of Ebola and Marburg viruses.";
RL   J. Virol. 80:10109-10116(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-702 AND TYR-703, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-866, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-884, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-702, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 33-227 IN COMPLEX WITH GAS6,
RP   MUTAGENESIS OF GLU-63; GLU-66 AND THR-84, AND SUBUNIT.
RX   PubMed=16362042; DOI=10.1038/sj.emboj.7600912;
RA   Sasaki T., Knyazev P.G., Clout N.J., Cheburkin Y., Goehring W.,
RA   Ullrich A., Timpl R., Hohenester E.;
RT   "Structural basis for Gas6-Axl signalling.";
RL   EMBO J. 25:80-87(2006).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-112; TRP-295; CYS-499 AND GLY-515.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May function as a signal transducer between specific
CC       cell types of mesodermal origin. In case of filovirus infection,
CC       seems to function as a cell entry factor.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Heterodimer and heterotetramer with GAS6.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P30530-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P30530-2; Sequence=VSP_005017;
CC   -!- TISSUE SPECIFICITY: Highly expressed in metastatic colon tumors.
CC       Expressed in primary colon tumors. Weakly expressed in normal
CC       colon tissue.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. AXL/UFO subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 2 Ig-like C2-type (immunoglobulin-like)
CC       domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M76125; AAA61243.1; -; mRNA.
DR   EMBL; S65125; AAB20305.1; -; mRNA.
DR   EMBL; X57019; CAA40338.1; -; mRNA.
DR   EMBL; AC011510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032229; AAH32229.1; -; mRNA.
DR   IPI; IPI00296992; -.
DR   IPI; IPI00397361; -.
DR   PIR; A41527; A41527.
DR   RefSeq; NP_001690.2; -.
DR   RefSeq; NP_068713.2; -.
DR   UniGene; Hs.590970; -.
DR   PDB; 2C5D; X-ray; 3.30 A; C/D=33-227.
DR   PDBsum; 2C5D; -.
DR   ProteinModelPortal; P30530; -.
DR   IntAct; P30530; 1.
DR   MINT; MINT-2735752; -.
DR   STRING; P30530; -.
DR   PhosphoSite; P30530; -.
DR   PRIDE; P30530; -.
DR   Ensembl; ENST00000301178; ENSP00000301178; ENSG00000167601.
DR   GeneID; 558; -.
DR   KEGG; hsa:558; -.
DR   UCSC; uc010ehj.1; human.
DR   UCSC; uc010ehk.1; human.
DR   CTD; 558; -.
DR   GeneCards; GC19P041725; -.
DR   HGNC; HGNC:905; AXL.
DR   MIM; 109135; gene.
DR   PharmGKB; PA25197; -.
DR   eggNOG; prNOG12486; -.
DR   HOGENOM; HBG444090; -.
DR   HOVERGEN; HBG006346; -.
DR   InParanoid; P30530; -.
DR   OMA; GSLHPHT; -.
DR   OrthoDB; EOG9SJ815; -.
DR   PhylomeDB; P30530; -.
DR   BRENDA; 2.7.10.1; 247.
DR   ArrayExpress; P30530; -.
DR   Bgee; P30530; -.
DR   CleanEx; HS_AXL; -.
DR   Genevestigator; P30530; -.
DR   GermOnline; ENSG00000167601; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kin...; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR007110; Ig-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR015775; Tyr_prot_kinase_rcpt_Axl-rel.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 4.
DR   PANTHER; PTHR23256:SF156; Axl_RTKs; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07686; V-set; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     25       Potential.
FT   CHAIN        26    894       Tyrosine-protein kinase receptor UFO.
FT                                /FTId=PRO_0000024481.
FT   TOPO_DOM     26    451       Extracellular (Potential).
FT   TRANSMEM    452    472       Helical; (Potential).
FT   TOPO_DOM    473    894       Cytoplasmic (Potential).
FT   DOMAIN       27    128       Ig-like C2-type 1.
FT   DOMAIN      139    222       Ig-like C2-type 2.
FT   DOMAIN      225    332       Fibronectin type-III 1.
FT   DOMAIN      333    427       Fibronectin type-III 2.
FT   DOMAIN      536    807       Protein kinase.
FT   NP_BIND     542    550       ATP (By similarity).
FT   REGION       26     92       Interaction with SKP1 and GAS6.
FT   ACT_SITE    672    672       Proton acceptor (By similarity).
FT   BINDING     567    567       ATP (By similarity).
FT   MOD_RES     100    100       Phosphoserine.
FT   MOD_RES     702    702       Phosphotyrosine.
FT   MOD_RES     703    703       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     866    866       Phosphotyrosine.
FT   MOD_RES     875    875       Phosphoserine.
FT   MOD_RES     884    884       Phosphoserine.
FT   CARBOHYD     43     43       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    157    157       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    198    198       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    339    339       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    345    345       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    401    401       N-linked (GlcNAc...) (Potential).
FT   DISULFID     56    117       By similarity.
FT   DISULFID    160    205       By similarity.
FT   VAR_SEQ     429    437       Missing (in isoform Short).
FT                                /FTId=VSP_005017.
FT   VARIANT     112    112       T -> M (in dbSNP:rs35202236).
FT                                /FTId=VAR_045596.
FT   VARIANT     266    266       N -> D (in dbSNP:rs7249222).
FT                                /FTId=VAR_057990.
FT   VARIANT     295    295       R -> W (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_045597.
FT   VARIANT     499    499       R -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041877.
FT   VARIANT     515    515       S -> G.
FT                                /FTId=VAR_041878.
FT   MUTAGEN      63     63       E->R: Slightly reduced affinity for GAS6.
FT   MUTAGEN      66     66       E->R: Reduced affinity for GAS6.
FT   MUTAGEN      84     84       T->R: Reduced affinity for GAS6.
FT   CONFLICT    303    303       T -> P (in Ref. 3; AAB20305/CAA40338).
FT   CONFLICT    338    338       E -> K (in Ref. 2; AAA61243).
FT   CONFLICT    430    430       Q -> E (in Ref. 3; AAB20305/CAA40338).
FT   CONFLICT    639    639       D -> G (in Ref. 3; AAB20305/CAA40338).
FT   CONFLICT    696    696       K -> I (in Ref. 7).
FT   CONFLICT    764    764       Q -> R (in Ref. 5; AAH32229).
FT   STRAND       36     39
FT   STRAND       44     46
FT   STRAND       52     63
FT   STRAND       68     71
FT   STRAND       80     87
FT   STRAND       89     91
FT   STRAND       94    106
FT   STRAND      113    121
FT   STRAND      124    127
FT   STRAND      131    135
FT   STRAND      140    143
FT   STRAND      148    150
FT   STRAND      156    163
FT   STRAND      170    177
FT   STRAND      179    183
FT   STRAND      190    194
FT   STRAND      201    209
FT   STRAND      212    215
FT   STRAND      219    223
SQ   SEQUENCE   894 AA;  98336 MW;  2C2D3574EADA4116 CRC64;
     MAWRCPRMGR VPLAWCLALC GWACMAPRGT QAEESPFVGN PGNITGARGL TGTLRCQLQV
     QGEPPEVHWL RDGQILELAD STQTQVPLGE DEQDDWIVVS QLRITSLQLS DTGQYQCLVF
     LGHQTFVSQP GYVGLEGLPY FLEEPEDRTV AANTPFNLSC QAQGPPEPVD LLWLQDAVPL
     ATAPGHGPQR SLHVPGLNKT SSFSCEAHNA KGVTTSRTAT ITVLPQQPRN LHLVSRQPTE
     LEVAWTPGLS GIYPLTHCTL QAVLSNDGMG IQAGEPDPPE EPLTSQASVP PHQLRLGSLH
     PHTPYHIRVA CTSSQGPSSW THWLPVETPE GVPLGPPENI SATRNGSQAF VHWQEPRAPL
     QGTLLGYRLA YQGQDTPEVL MDIGLRQEVT LELQGDGSVS NLTVCVAAYT AAGDGPWSLP
     VPLEAWRPGQ AQPVHQLVKE PSTPAFSWPW WYVLLGAVVA AACVLILALF LVHRRKKETR
     YGEVFEPTVE RGELVVRYRV RKSYSRRTTE ATLNSLGISE ELKEKLRDVM VDRHKVALGK
     TLGEGEFGAV MEGQLNQDDS ILKVAVKTMK IAICTRSELE DFLSEAVCMK EFDHPNVMRL
     IGVCFQGSER ESFPAPVVIL PFMKHGDLHS FLLYSRLGDQ PVYLPTQMLV KFMADIASGM
     EYLSTKRFIH RDLAARNCML NENMSVCVAD FGLSKKIYNG DYYRQGRIAK MPVKWIAIES
     LADRVYTSKS DVWSFGVTMW EIATRGQTPY PGVENSEIYD YLRQGNRLKQ PADCLDGLYA
     LMSRCWELNP QDRPSFTELR EDLENTLKAL PPAQEPDEIL YVNMDEGGGY PEPPGAAGGA
     DPPTQPDPKD SCSCLTAAEV HPAGRYVLCP STTPSPAQPA DRGSPAAPGQ EDGA
//
